RxDoctor Payments Data

Lindsey Fails

Nurse Practitioner · Spokane Valley, WANPI 1972046118

Payments from drug & device makers

$1,200in general payments, 2019–2025

Across 66 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$421
  • Novo Nordisk$406
  • Pfizer$121
  • Lilly USA, LLC$59
  • Boehringer Ingelheim$51
  • Merck$49
  • plus $94 from 5 others

What the payments were for

  • Food & beverage$1,200100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,200 in reported general payments places this provider in the 90th percentile of 2,466 nurse practitioner providers in Washington.

See all nurse practitioner providers in Washington

Medicare billing

Part B allowed, 2024
$50,648
Medicare patients
190
Services billed
588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide28$40,242
EliquisApixaban16$13,771
TrintellixVortioxetine Hydrobromide11$4,944
Rosuvastatin Calcium65$970
Atorvastatin Calcium90$956
Albuterol Sulfate HfaAlbuterol Sulfate43$894
Losartan Potassium26$431
Levothyroxine Sodium70$423
Lisinopril68$406
Metoprolol Succinate18$355
Diclofenac Sodium13$296
Omeprazole42$272
Lorazepam15$259
Pantoprazole Sodium22$252
Metformin Hcl17$217

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$406$40,24228 claims
PfizerEliquis$121$13,77116 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$14$4,94411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,466 nurse practitioner providers in Washington.

Other nurse practitioner in Spokane Valley

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →